Hepatitis A Vaccines
Immunization Would be Economically Beneficial in Argentine Children
Published in Hepatitis Weekly, November 13th, 2000
"HAV remains one of the most frequently reported vaccine-preventable diseases in Argentine children," reported Roberto Debbag and colleagues from the Fundacion Center de Estudios Infectologicos and the Hospital J.P. Garrahan, Buenos Aires. "Although an inactivated vaccine is available, no economic analysis of mass immunization strategies against HAV has been carried out in our country."
Debbag et al. presented data from their study at the 38th annual meeting of the Infectious Disease Society of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2000-11-13)
More Articles from Hepatitis Weekly
- Therapy (HBV)
Plasma Kinetics Don't Explain Why Some Hepatitis B Patients are Non-Responders to Lamivudine - Cirrhosis
Study Questions Validity of AST/ALT Ratio to Predict Liver Disease in HCV Patients - Coinfection (HCV/HIV)
Incidence of Hepatitis C Virus Low in HIV Patients in Singapore - Gastroenterology
Cirrhosis, Not Hepatitis B Virus, Slows Gastrointestinal Motility - Hepatitis B Vaccines
DNA Vaccine Stimulates Unique Immunogenicity - Hepatitis Delta Virus
Study Results Explain Why Hepatitis D Won't Replicate in Avian Cells - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
